ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 73 | -81.8% | 0.00% | -100.0% |
| Q1 2018 | $1,000 | -50.0% | 400 | -20.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | -84.6% | 500 | -80.0% | 0.00% | -87.5% |
| Q3 2017 | $13,000 | +160.0% | 2,500 | +150.0% | 0.01% | +166.7% |
| Q2 2017 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
| Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
| Founders Capital Management | 18,000 | $20,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |